List of Tables
Table 1. Global TKI for Chronic Myeloid Leukemia Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global TKI for Chronic Myeloid Leukemia Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global TKI for Chronic Myeloid Leukemia Market Competitive Situation by Manufacturers in 2025
Table 4. Global TKI for Chronic Myeloid Leukemia Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global TKI for Chronic Myeloid Leukemia Sales Market Share by Manufacturers (2021–2026)
Table 6. Global TKI for Chronic Myeloid Leukemia Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global TKI for Chronic Myeloid Leukemia Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market TKI for Chronic Myeloid Leukemia Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of TKI for Chronic Myeloid Leukemia, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of TKI for Chronic Myeloid Leukemia, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of TKI for Chronic Myeloid Leukemia, Product Types and Applications
Table 12. Global Key Manufacturers of TKI for Chronic Myeloid Leukemia, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global TKI for Chronic Myeloid Leukemia Companies by Tier (Tier 1, Tier 2, Tier 3), based on TKI for Chronic Myeloid Leukemia Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global TKI for Chronic Myeloid Leukemia Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global TKI for Chronic Myeloid Leukemia Sales by Region (K Units), 2021–2026
Table 18. Global TKI for Chronic Myeloid Leukemia Sales Market Share by Region (2021–2026)
Table 19. Global TKI for Chronic Myeloid Leukemia Sales by Region (K Units), 2027–2032
Table 20. Global TKI for Chronic Myeloid Leukemia Sales Market Share by Region (2027–2032)
Table 21. Global TKI for Chronic Myeloid Leukemia Revenue by Region (US$ Million), 2021–2026
Table 22. Global TKI for Chronic Myeloid Leukemia Revenue Market Share by Region (2021–2026)
Table 23. Global TKI for Chronic Myeloid Leukemia Revenue by Region (US$ Million), 2027–2032
Table 24. Global TKI for Chronic Myeloid Leukemia Revenue Market Share by Region (2027–2032)
Table 25. North America TKI for Chronic Myeloid Leukemia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America TKI for Chronic Myeloid Leukemia Sales by Country (K Units), 2021–2026
Table 27. North America TKI for Chronic Myeloid Leukemia Sales by Country (K Units), 2027–2032
Table 28. North America TKI for Chronic Myeloid Leukemia Revenue by Country (US$ Million), 2021–2026
Table 29. North America TKI for Chronic Myeloid Leukemia Revenue by Country (US$ Million), 2027–2032
Table 30. Europe TKI for Chronic Myeloid Leukemia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe TKI for Chronic Myeloid Leukemia Sales by Country (K Units), 2021–2026
Table 32. Europe TKI for Chronic Myeloid Leukemia Sales by Country (K Units), 2027–2032
Table 33. Europe TKI for Chronic Myeloid Leukemia Revenue by Country (US$ Million), 2021–2026
Table 34. Europe TKI for Chronic Myeloid Leukemia Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific TKI for Chronic Myeloid Leukemia Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific TKI for Chronic Myeloid Leukemia Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific TKI for Chronic Myeloid Leukemia Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific TKI for Chronic Myeloid Leukemia Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific TKI for Chronic Myeloid Leukemia Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America TKI for Chronic Myeloid Leukemia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America TKI for Chronic Myeloid Leukemia Sales by Country (K Units), 2021–2026
Table 42. Latin America TKI for Chronic Myeloid Leukemia Sales by Country (K Units), 2027–2032
Table 43. Latin America TKI for Chronic Myeloid Leukemia Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America TKI for Chronic Myeloid Leukemia Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa TKI for Chronic Myeloid Leukemia Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa TKI for Chronic Myeloid Leukemia Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa TKI for Chronic Myeloid Leukemia Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa TKI for Chronic Myeloid Leukemia Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa TKI for Chronic Myeloid Leukemia Revenue by Country (US$ Million), 2027–2032
Table 50. Global TKI for Chronic Myeloid Leukemia Sales (K Units) by Type (2021–2026)
Table 51. Global TKI for Chronic Myeloid Leukemia Sales (K Units) by Type (2027–2032)
Table 52. Global TKI for Chronic Myeloid Leukemia Sales Market Share by Type (2021–2026)
Table 53. Global TKI for Chronic Myeloid Leukemia Sales Market Share by Type (2027–2032)
Table 54. Global TKI for Chronic Myeloid Leukemia Revenue (US$ Million) by Type (2021–2026)
Table 55. Global TKI for Chronic Myeloid Leukemia Revenue (US$ Million) by Type (2027–2032)
Table 56. Global TKI for Chronic Myeloid Leukemia Revenue Market Share by Type (2021–2026)
Table 57. Global TKI for Chronic Myeloid Leukemia Revenue Market Share by Type (2027–2032)
Table 58. Global TKI for Chronic Myeloid Leukemia Price (US$/Unit) by Type (2021–2026)
Table 59. Global TKI for Chronic Myeloid Leukemia Price (US$/Unit) by Type (2027–2032)
Table 60. Global TKI for Chronic Myeloid Leukemia Sales (K Units) by Application (2021–2026)
Table 61. Global TKI for Chronic Myeloid Leukemia Sales (K Units) by Application (2027–2032)
Table 62. Global TKI for Chronic Myeloid Leukemia Sales Market Share by Application (2021–2026)
Table 63. Global TKI for Chronic Myeloid Leukemia Sales Market Share by Application (2027–2032)
Table 64. Global TKI for Chronic Myeloid Leukemia Revenue (US$ Million) by Application (2021–2026)
Table 65. Global TKI for Chronic Myeloid Leukemia Revenue (US$ Million) by Application (2027–2032)
Table 66. Global TKI for Chronic Myeloid Leukemia Revenue Market Share by Application (2021–2026)
Table 67. Global TKI for Chronic Myeloid Leukemia Revenue Market Share by Application (2027–2032)
Table 68. Global TKI for Chronic Myeloid Leukemia Price (US$/Unit) by Application (2021–2026)
Table 69. Global TKI for Chronic Myeloid Leukemia Price (US$/Unit) by Application (2027–2032)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Novartis TKI for Chronic Myeloid Leukemia Product
Table 74. Novartis Recent Developments/Updates
Table 75. Bristol Myers Squibb Company Information
Table 76. Bristol Myers Squibb Description and Business Overview
Table 77. Bristol Myers Squibb TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Bristol Myers Squibb TKI for Chronic Myeloid Leukemia Product
Table 79. Bristol Myers Squibb Recent Developments/Updates
Table 80. Pfizer Company Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pfizer TKI for Chronic Myeloid Leukemia Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Hansoh Pharmaceutical Company Information
Table 86. Hansoh Pharmaceutical Description and Business Overview
Table 87. Hansoh Pharmaceutical TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Hansoh Pharmaceutical TKI for Chronic Myeloid Leukemia Product
Table 89. Hansoh Pharmaceutical Recent Developments/Updates
Table 90. Takeda Pharmaceuticals Company Information
Table 91. Takeda Pharmaceuticals Description and Business Overview
Table 92. Takeda Pharmaceuticals TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Takeda Pharmaceuticals TKI for Chronic Myeloid Leukemia Product
Table 94. Takeda Pharmaceuticals Recent Developments/Updates
Table 95. Sun Pharmaceuticals Company Information
Table 96. Sun Pharmaceuticals Description and Business Overview
Table 97. Sun Pharmaceuticals TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Sun Pharmaceuticals TKI for Chronic Myeloid Leukemia Product
Table 99. Sun Pharmaceuticals Recent Developments/Updates
Table 100. Mylan Company Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Mylan TKI for Chronic Myeloid Leukemia Product
Table 104. Mylan Recent Developments/Updates
Table 105. Dr. Reddy's Laboratories Company Information
Table 106. Dr. Reddy's Laboratories Description and Business Overview
Table 107. Dr. Reddy's Laboratories TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Dr. Reddy's Laboratories TKI for Chronic Myeloid Leukemia Product
Table 109. Dr. Reddy's Laboratories Recent Developments/Updates
Table 110. Teva Company Information
Table 111. Teva Description and Business Overview
Table 112. Teva TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Teva TKI for Chronic Myeloid Leukemia Product
Table 114. Teva Recent Developments/Updates
Table 115. Eugia Pharma Company Information
Table 116. Eugia Pharma Description and Business Overview
Table 117. Eugia Pharma TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Eugia Pharma TKI for Chronic Myeloid Leukemia Product
Table 119. Eugia Pharma Recent Developments/Updates
Table 120. Hetero Company Information
Table 121. Hetero Description and Business Overview
Table 122. Hetero TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Hetero TKI for Chronic Myeloid Leukemia Product
Table 124. Hetero Recent Developments/Updates
Table 125. Sawai Pharmaceutical Company Information
Table 126. Sawai Pharmaceutical Description and Business Overview
Table 127. Sawai Pharmaceutical TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Sawai Pharmaceutical TKI for Chronic Myeloid Leukemia Product
Table 129. Sawai Pharmaceutical Recent Developments/Updates
Table 130. Lupin Company Information
Table 131. Lupin Description and Business Overview
Table 132. Lupin TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Lupin TKI for Chronic Myeloid Leukemia Product
Table 134. Lupin Recent Developments/Updates
Table 135. Apotex Company Information
Table 136. Apotex Description and Business Overview
Table 137. Apotex TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Apotex TKI for Chronic Myeloid Leukemia Product
Table 139. Apotex Recent Developments/Updates
Table 140. Chia Tai Tianqing Pharmaceutical Company Information
Table 141. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 142. Chia Tai Tianqing Pharmaceutical TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Chia Tai Tianqing Pharmaceutical TKI for Chronic Myeloid Leukemia Product
Table 144. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 145. Qilu Pharmaceutical Company Information
Table 146. Qilu Pharmaceutical Description and Business Overview
Table 147. Qilu Pharmaceutical TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Qilu Pharmaceutical TKI for Chronic Myeloid Leukemia Product
Table 149. Qilu Pharmaceutical Recent Developments/Updates
Table 150. CSPC Ouyi Pharmaceutical Company Information
Table 151. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 152. CSPC Ouyi Pharmaceutical TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. CSPC Ouyi Pharmaceutical TKI for Chronic Myeloid Leukemia Product
Table 154. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 155. Suzhou Thery Pharmaceutical Company Information
Table 156. Suzhou Thery Pharmaceutical Description and Business Overview
Table 157. Suzhou Thery Pharmaceutical TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Suzhou Thery Pharmaceutical TKI for Chronic Myeloid Leukemia Product
Table 159. Suzhou Thery Pharmaceutical Recent Developments/Updates
Table 160. Lunan Pharmaceutical Company Information
Table 161. Lunan Pharmaceutical Description and Business Overview
Table 162. Lunan Pharmaceutical TKI for Chronic Myeloid Leukemia Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Lunan Pharmaceutical TKI for Chronic Myeloid Leukemia Product
Table 164. Lunan Pharmaceutical Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. TKI for Chronic Myeloid Leukemia Distributors List
Table 168. TKI for Chronic Myeloid Leukemia Customers List
Table 169. TKI for Chronic Myeloid Leukemia Market Trends
Table 170. TKI for Chronic Myeloid Leukemia Market Drivers
Table 171. TKI for Chronic Myeloid Leukemia Market Challenges
Table 172. TKI for Chronic Myeloid Leukemia Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
Table 176. Authors List of This Report
List of Figures
Figure 1. Product Picture of TKI for Chronic Myeloid Leukemia
Figure 2. Global TKI for Chronic Myeloid Leukemia Market Value by Type (US$ Million), 2021–2032
Figure 3. Global TKI for Chronic Myeloid Leukemia Market Share by Type: 2025 & 2032
Figure 4. Imatinib Product Picture
Figure 5. Nilotinib Product Picture
Figure 6. Dasatinib Product Picture
Figure 7. Bosutinib Product Picture
Figure 8. Flumatinib Product Picture
Figure 9. Ponatinib Product Picture
Figure 10. Asciminib Product Picture
Figure 11. Other Product Picture
Figure 12. Global TKI for Chronic Myeloid Leukemia Market Value by Application (US$ Million), 2021–2032
Figure 13. Global TKI for Chronic Myeloid Leukemia Market Share by Application: 2025 & 2032
Figure 14. Hospitals and clinics
Figure 15. Pharmacies
Figure 16. Others
Figure 17. Global TKI for Chronic Myeloid Leukemia Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 18. Global TKI for Chronic Myeloid Leukemia Market Size (US$ Million), 2021–2032
Figure 19. Global TKI for Chronic Myeloid Leukemia Sales (K Units), 2021–2032
Figure 20. Global TKI for Chronic Myeloid Leukemia Average Price (US$/Unit), 2021–2032
Figure 21. TKI for Chronic Myeloid Leukemia Report Years Considered
Figure 22. TKI for Chronic Myeloid Leukemia Sales Share by Manufacturers in 2025
Figure 23. Global TKI for Chronic Myeloid Leukemia Revenue Share by Manufacturers in 2025
Figure 24. Top 5 and Top 10 Global TKI for Chronic Myeloid Leukemia Players: Market Share by Revenue in TKI for Chronic Myeloid Leukemia in 2025
Figure 25. TKI for Chronic Myeloid Leukemia Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 26. Global TKI for Chronic Myeloid Leukemia Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 27. North America TKI for Chronic Myeloid Leukemia Sales Market Share by Country (2021–2032)
Figure 28. North America TKI for Chronic Myeloid Leukemia Revenue Market Share by Country (2021–2032)
Figure 29. United States TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Canada TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Europe TKI for Chronic Myeloid Leukemia Sales Market Share by Country (2021–2032)
Figure 32. Europe TKI for Chronic Myeloid Leukemia Revenue Market Share by Country (2021–2032)
Figure 33. Germany TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. France TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. U.K. TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Italy TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Russia TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Asia Pacific TKI for Chronic Myeloid Leukemia Sales Market Share by Region (2021–2032)
Figure 39. Asia Pacific TKI for Chronic Myeloid Leukemia Revenue Market Share by Region (2021–2032)
Figure 40. China TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Japan TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. South Korea TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. India TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Australia TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. China Taiwan TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Southeast Asia TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Latin America TKI for Chronic Myeloid Leukemia Sales Market Share by Country (2021–2032)
Figure 48. Latin America TKI for Chronic Myeloid Leukemia Revenue Market Share by Country (2021–2032)
Figure 49. Mexico TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Brazil TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Argentina TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Colombia TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Middle East and Africa TKI for Chronic Myeloid Leukemia Sales Market Share by Country (2021–2032)
Figure 54. Middle East and Africa TKI for Chronic Myeloid Leukemia Revenue Market Share by Country (2021–2032)
Figure 55. Turkey TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Saudi Arabia TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. UAE TKI for Chronic Myeloid Leukemia Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Global Sales Market Share of TKI for Chronic Myeloid Leukemia by Type (2021–2032)
Figure 59. Global Revenue Market Share of TKI for Chronic Myeloid Leukemia by Type (2021–2032)
Figure 60. Global TKI for Chronic Myeloid Leukemia Price (US$/Unit) by Type (2021–2032)
Figure 61. Global Sales Market Share of TKI for Chronic Myeloid Leukemia by Application (2021–2032)
Figure 62. Global Revenue Market Share of TKI for Chronic Myeloid Leukemia by Application (2021–2032)
Figure 63. Global TKI for Chronic Myeloid Leukemia Price (US$/Unit) by Application (2021–2032)
Figure 64. TKI for Chronic Myeloid Leukemia Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
